Cover Image
市場調查報告書

消化器官系統醫藥品的全球市場:制酸劑·抗潰瘍藥·維他命&礦物質·抗肥胖藥·制吐藥·止瀉藥

Gastrointestinal Drugs Global Market Report 2018

出版商 The Business Research Company 商品編碼 531327
出版日期 內容資訊 英文 125 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
消化器官系統醫藥品的全球市場:制酸劑·抗潰瘍藥·維他命&礦物質·抗肥胖藥·制吐藥·止瀉藥 Gastrointestinal Drugs Global Market Report 2018
出版日期: 2018年02月01日 內容資訊: 英文 125 Pages
簡介

本報告提供全球消化器官系統醫藥品的市場調查,提供市場定義和概要,市場的各種影響因素分析,各藥物部門·各地各國趨勢與市場規模的變化與預測,並彙整與宏觀經濟因素·醫療保健市場全體·各種產業指標的比較,競爭環境,企業簡介等資料。

第1章 市場特徵

第2章 市場規模·成長率

  • 市場成長:迄今的過程
    • 成長推進因素
    • 阻礙成長要素
  • 市場成長:預測
    • 成長推進因素
    • 阻礙成長要素

第3章 大環境分析

第4章 客戶資訊

第5章 消化器官系統醫藥品市場分析:各種類

  • 全球市場的實際成果:各種類
    • 制酸劑
    • 抗潰瘍藥
    • 維生素和礦物質
    • 抗肥胖藥
    • 制吐藥
    • 止瀉藥
  • 全球市場的變化與預測:各種類
  • 市場趨勢·策略

第6章 消化器官系統醫藥品市場分析:各地各國分析

  • 全球市場的實際成果:各地區
  • 全球市場的變化與預測:各地區
  • 市場實際成果:各國
  • 市場變化與預測:各國
  • 全球醫藥品市場實際成果:部門·各地區
  • 全球醫藥品市場實際成果:部門·各國

第7章 宏觀經濟因素與市場比較

  • 市場規模的佔 GDP的百分比
  • 平均每個人的平均支出額

第8章 宏觀經濟因素與市場比較:各國

  • 市場規模的佔 GDP的百分比:各國
  • 平均每個人的平均支出額:各國

第9章 產業指標與市場比較

  • 全球藥劑師數:各國
  • 市場收益 vs 藥劑師數:各國
  • 全球醫藥品公司數:各國
  • 市場收益 vs 醫藥品公司數:各國
  • 全球對R&D/產品開發的平均支出額:各國
  • 市場收益 vs 對R&D/產品開發的平均支出額:各國
  • 全球非專利&品牌銷售額的比例:各國
  • 市場收益 vs 非專利&品牌銷售額的比例:各國
  • 消化性潰瘍的患病人數:各國
  • 全球一般開業醫生數:各國
  • 市場收益 vs 一般開業醫生數:各國

第10章 亞太地區市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 中國
  • 印度
  • 日本
  • 澳洲

第11章 西歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙

第12章 東歐市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 俄羅斯

第13章 北美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 美國

第14章 南美市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類
  • 各國分析
  • 巴西

第15章 中東市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第16章 非洲市場

  • 市場概要
  • 市場過去的轉變
  • 市場預測
  • 市場實際成果:各種類

第17章 競爭環境

  • 企業簡介
  • Abbvie
  • Johnson & Johnson
  • 武田藥品工業
  • Allergan
  • Ucb

第18章 主要M&A:消化器官系統醫藥品市場

第19章 市場背景:醫藥品市場

第20章 醫藥品產業的Financial Margins

第21章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Gastrointestinal Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global gastrointestinal drugs market.

Where is the largest and fastest growing market for the gastrointestinal drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gastrointestinal drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.

Scope:

Markets Covered: Antiulcerants; Vitamin And Minerals; Antacids; Antiemetics And Antinauseants ; Antiobesity; Antidiarrhoeals

Companies Mentioned: Takeda Pharmaceticals,Allergan Plc,Novo Nordisk A/S,AstraZeneca Plc,Johnson & Johnson

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Gastrointestinal Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Reasons to Purchase:

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

1. Gastrointestinal Drugs Market Characteristics

2. Gastrointestinal Drugs Market Size And Growth

  • 2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
    • 2.1.1. Drivers Of The Market
    • 2.1.2. Restraints On The Market
  • 2.2. Forecast Market Growth, Value ($ Billion)
    • 2.2.1. Drivers Of The Market
    • 2.2.2. Restraints On The Market

3. Gastrointestinal Drugs Trends And Strategies

4. Pestle Analysis

  • 4.1. Political
  • 4.2. Economic
  • 4.3. Social
  • 4.4. Technological
  • 4.5. Legal
  • 4.6. Environmental

5. Gastrointestinal Drugs Market Customer Information

6. Gastrointestinal Drugs Market Regional And Country Analysis

  • 6.1. Global Gastrointestinal Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
  • 6.2. Global Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, By Region
  • 6.3. Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Region
  • 6.4. Global Gastrointestinal Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
  • 6.5. Global Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, By Country
  • 6.6. Global Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Country

7. Gastrointestinal Drugs Market Segmentation

  • 7.1. Global Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

  • 7.2. Global Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

8. Gastrointestinal Drugs Market Segments

  • 8.1.Antiulcerants

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antiulcerants Market, 2017, By Segment, Value ($ Billion)

  • 8.2.Vitamin And Minerals

a) Market Characteristics

b) Market Trends & Strategies

c) Global Vitamin And Minerals Market, 2017, By Segment, Value ($ Billion)

  • 8.3.Antacids

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antacids Market, 2017, By Segment, Value ($ Billion)

  • 8.4.Antiemetics And Antinauseants

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antiemetics And Antinauseants Market, 2017, By Segment, Value ($ Billion)

  • 8.5.Antiobesity

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antiobesity Market, 2017, By Segment, Value ($ Billion)

  • 8.6.Antidiarrhoeals

a) Market Characteristics

b) Market Trends & Strategies

c) Global Antidiarrhoeals Market, 2017, By Segment, Value ($ Billion)

9. Global Gastrointestinal Drugs Market Comparison With Macro Economic Factors

  • 9.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, Global
  • 9.2. Per Capita Average Gastrointestinal Drugs Expenditure, Global

10. Gastrointestinal Drugs Market Comparison With Macro Economic Factors Across Countries

  • 10.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, By Country
  • 10.2. Per Capita Average Gastrointestinal Drugs Expenditure, By Country

11. Gastrointestinal Drugs Market Comparison With Industry Metrics

  • 11.1. Global Number Of Pharmacists, 2017, By Country
  • 11.2. Global Gastrointestinal Diseases Market Revenue Versus Number Of Pharmacists, 2017, By Country
  • 11.3. Global Number Of Pharma Enterprises, 2017, By Country
  • 11.4. Global Gastrointestinal Diseases Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
  • 11.5. Global Average Spending On R&D/Product Development, 2017, By Country
  • 11.6. Global Gastrointestinal Diseases Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
  • 11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.8. Global Gastrointestinal Diseases Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
  • 11.9. Prevalent Cases of Peptic Ulcer, 2014, By Country
  • 11.10. Global Number Of General Practitioners 2017, By Country
  • 11.11. Global Gastrointestinal Diseases Market Revenue Versus Number Of General Practitioners, 2017, By Country

12. Asia-Pacific Gastrointestinal Drugs Market

    • 12.1.1. Asia-Pacific Gastrointestinal Drugs Market Overview
    • 12.1.2. Asia-Pacific Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.1.3. Asia-Pacific Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.1.4. Asia-Pacific Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.1.5. Asia-Pacific Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.2. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis
  • 12.3. China Gastrointestinal Drugs Market
    • 12.3.1. China Gastrointestinal Drugs Market Overview
    • 12.3.2. China Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.3.3. China Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.3.4. China Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.3.5. China Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.4. India Gastrointestinal Drugs Market
    • 12.4.1. India Gastrointestinal Drugs Market Overview
    • 12.4.2. India Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.4.3. India Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.4.4. India Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.4.5. India Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.5. Japan Gastrointestinal Drugs Market
    • 12.5.1. Japan Gastrointestinal Drugs Market Overview
    • 12.5.2. Japan Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.5.3. Japan Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.5.4. Japan Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.5.5. Japan Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 12.6. Australia Gastrointestinal Drugs Market
    • 12.6.1. Australia Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 12.6.2. Australia Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 12.6.3. Australia Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 12.6.4. Australia Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

13. Western Europe Gastrointestinal Drugs Market

    • 13.1.1. Western Europe Gastrointestinal Drugs Market Overview
    • 13.1.2. Western Europe Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.1.3. Western Europe Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.1.4. Western Europe Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.1.5. Western Europe Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.2. Western Europe Gastrointestinal Drugs Market: Country Analysis
  • 13.3. UK Gastrointestinal Drugs Market
    • 13.3.1. UK Gastrointestinal Drugs Market Overview
    • 13.3.2. UK Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.3.3. UK Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.3.4. UK Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.3.5. UK Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.4. Germany Gastrointestinal Drugs Market
    • 13.4.1. Germany Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.4.2. Germany Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.4.3. Germany Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.4.4. Germany Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.5 France Gastrointestinal Drugs Market
    • 13.5.1 France Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.5.2 France Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.5.3. France Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.5.4. France Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.6. Italy Gastrointestinal Drugs Market
    • 13.6.1. Italy Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.6.2. Italy Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.6.3. Italy Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.6.4. Italy Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 13.7. Spain Gastrointestinal Drugs Market
    • 13.7.1. Spain Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 13.7.2. Spain Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 13.7.3. Spain Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 13.7.4. Spain Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Gastrointestinal Drugs Market

    • 14.1.1. Eastern Europe Gastrointestinal Drugs Market Overview
    • 14.1.2. Eastern Europe Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.1.3. Eastern Europe Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.1.4. Eastern Europe Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 14.1.5. Eastern Europe Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 14.2. Eastern Europe Gastrointestinal Drugs Market: Country Analysis
  • 14.3. Russia Gastrointestinal Drugs Market
    • 14.3.1. Russia Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 14.3.2. Russia Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 14.3.3. Russia Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 14.3.4. Russia Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

15. North America Gastrointestinal Drugs Market

    • 15.1.1. North America Gastrointestinal Drugs Market Overview
    • 15.1.2. North America Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.1.3. North America Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.1.4. North America Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 15.1.5. North America Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 15.2. North America Gastrointestinal Drugs Market: Country Analysis
  • 15.3. USA Gastrointestinal Drugs Market
    • 15.3.1. USA Gastrointestinal Drugs Market Overview
    • 15.3.2. USA Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 15.3.3. USA Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 15.3.4. USA Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 15.3.5. USA Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

16. South America Gastrointestinal Drugs Market

    • 16.1.1. South America Gastrointestinal Drugs Market Overview
    • 16.1.2. South America Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.1.3. South America Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.1.4. South America Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 16.1.5. South America Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
  • 16.2. South America Gastrointestinal Drugs Market: Country Analysis
  • 16.3. Brazil Gastrointestinal Drugs Market
    • 16.3.1. Brazil Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 16.3.2. Brazil Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 16.3.3. Brazil Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 16.3.4. Brazil Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

17. Middle East Gastrointestinal Drugs Market

    • 17.1.1. Middle East Gastrointestinal Drugs Market Overview
    • 17.1.2. Middle East Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 17.1.3. Middle East Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 17.1.4. Middle East Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 17.1.5. Middle East Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

18. Africa Gastrointestinal Drugs Market

    • 18.1.1. Africa Gastrointestinal Drugs Market Overview
    • 18.1.2. Africa Gastrointestinal Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
    • 18.1.3. Africa Gastrointestinal Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
    • 18.1.4. Africa Gastrointestinal Drugs Market, 2017, Segmentation By Type, Value ($ Billion)

Antiulcerants

Vitamin And Minerals

Antacids

Antiemetics And Antinauseants

Antiobesity

Antidiarrhoeals

    • 18.1.5. Africa Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)

19. Gastrointestinal Drugs Market Competitive Landscape

  • 19.1. Company Profiles
  • 19.2. Takeda Pharmaceticals
    • 19.2.1. Overview
    • 19.2.2. Products And Services
    • 19.2.3. Strategy
    • 19.2.4. Financial Performance
  • 19.3. Allergan Plc
    • 19.3.1. Overview
    • 19.3.2. Products And Services
    • 19.3.3. Strategy
    • 19.3.4. Financial Performance
  • 19.4. Novo Nordisk A/S
    • 19.4.1. Overview
    • 19.4.2. Products And Services
    • 19.4.3. Strategy
    • 19.4.4. Financial Performance
  • 19.5. AstraZeneca Plc
    • 19.5.1. Overview
    • 19.5.2. Products And Services
    • 19.5.3. Strategy
    • 19.5.4. Financial Performance
  • 19.6. Johnson & Johnson
    • 19.6.1. Overview
    • 19.6.2. Products And Services
    • 19.6.3. Strategy
    • 19.6.4. Financial Performance

20. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market

21. Market Background: Gastrointestinal Drugs Market

    • 21.1.1. Gastrointestinal Drugs Market Characteristics
    • 21.1.2. Gastrointestinal Drugs Market Historic Growth, Value ($ Billion)
      • 21.1.2.1. Drivers Of The Market
      • 21.1.2.2. Restraints Of The Market
    • 21.1.3. Gastrointestinal Drugs Market Forecast Growth, Value ($ Billion)
      • 21.1.3.1. Drivers Of The Market
      • 21.1.3.2. Restraints Of The Market
    • 21.1.4. Gastrointestinal Drugs Trends And Strategies
  • 21.2. Gastrointestinal Drugs Market Regional And Country Analysis
    • 21.2.1. Global Gastrointestinal Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
    • 21.2.2. Global Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, By Region
    • 21.2.3. Gastrointestinal Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
    • 21.2.4. Gastrointestinal Drugs Market, 2013 - 2021, Historic And Forecast, By Country
    • 21.2.5. Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Segment
    • 21.2.6. Gastrointestinal Drugs Market, Growth And Market Share Comparison, By Country And Segment
  • 21.3. Global Gastrointestinal Drugs Market Comparison With Macro Economic Factors
    • 21.3.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, Global
    • 21.3.2. Per Capita Average Gastrointestinal Drugs Expenditure, Global
  • 21.4. Gastrointestinal Drugs Market Comparison With Macro Economic Factors Across Countries
    • 21.4.1. Gastrointestinal Drugs Market Size, Percentage Of GDP, By Country
    • 21.4.2. Per Capita Average Gastrointestinal Drugs Expenditure, By Country
  • 21.5. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market

22. Appendix

  • 22.1. NAICS Definitions Of Industry Covered In This Report
  • 22.2. Abbreviations
  • 22.3. Currencies
  • 22.4. Research Inquiries
  • 22.5. The Business Research Company
  • 22.6. Copyright And Disclaimer
Back to Top